CVRx, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 6.38K shares, a 71.02% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 36.50K shares, a 80.15% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 41.16K shares, a 80.60% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 47.78K shares, a 63.95% decline year-over-year.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 294.80K shares, a 42.27% decline from fiscal 2024.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 510.67K shares, a 254.17% increase from fiscal 2023.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 144.19K shares, a 4.20% decline from fiscal 2022.
- CVRx, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 150.51K shares, a 153.63% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 6.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 131.82K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 36.50K shares 10-Q · filed 2026-05-12 | 147.46K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 41.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 294.80K shares 10-K · filed 2026-02-13 |
| 2025-09-30 | 47.78K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 465.80K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | 22.02K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 550.54K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | 183.85K shares 10-Q · filed 2025-05-09 | 607.90K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | 212.16K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 510.67K shares 10-K · filed 2026-02-13 |
| 2024-09-30 | 132.53K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | 327.25K shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-06-30 | 79.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | 257.42K shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2024-03-31 | 86.61K shares 10-Q · filed 2024-05-10 | 185.59K shares derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-12-31 | 28.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | 144.19K shares 10-K · filed 2025-02-18 |
| 2023-09-30 | 62.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | 144.02K shares derived: sum of 4 quarters · filed 2023-10-31 |
| 2023-06-30 | 7.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 84.13K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 45.20K shares 10-Q · filed 2023-05-11 | 108.08K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 28.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 150.51K shares 10-K · filed 2023-02-10 |
| 2022-09-30 | 2.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | 169.50K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-06-30 | 31.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | 172.54K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2022-03-31 | 87.63K shares 10-Q · filed 2022-05-02 | |
| 2021-12-31 | 47.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 59.34K shares 10-K · filed 2023-02-10 |
| 2021-09-30 | 5.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | |
| 2020-12-31 | 175.00 shares 10-K · filed 2022-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |